can tirzepatide cause cancer Mounjaro® (Tirzepatide) and Thyroid Risk | ClinicOl Mounjaro® (Tirzepatide) and Thyroid Cancer

Wewer Albrechtsen discuss the recently published research titled "Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease." The authors reveal that patients with autoimmune liver disease, even in the absence of overt diabetes, experience early glucose disturbances

Teva Pharmaceuticals has received FDA approval for its generic version of Saxenda, the first generic GLP-1 obesity medication in the U.S., offering a more affordable weight-loss solution for adults and adolescents.

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S

Securing Weight Loss Medication Deliveries: Are You Protected?

Parliamo dei pro, dei contro e di come somministrarlo.